Patent details

91819 Product Name: Ticagrelor ou ses sels pharmacologiquement acceptables

Basic Information

Publication number:
91819
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP999637960
Legal Status:
Active
Application number:
91819
First applicant's nationality:
Procedural language:
French

Paediatric Extension

SPC Extension Filing Date:
17/03/2022
SPC Extension Agent Name:
ARONOVA S.A.
SPC Extension Status:
Granted
SPC Extension Grant Date:
27/03/2024
SPC Extension Rejection Date:

Marketing Authorization

Marketing Authorization Number:
EU/1/10/655/001-006 - Brilique
Marketing Authorization Type:
Marketing Authorization Date:
03/12/2010
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
31/05/2011
First Marketing Authorization date:
03/12/2010
Grant date:
01/08/2011
Activation date:
02/12/2019
Publication date:
01/08/2011
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
02/12/2024
SPC Extension Expiration:
02/06/2025
Rejection date:
Withdrawal date:

Owner

From:
31/05/2011
 
 

Name:
AstraZeneca AB
Address:
-, 151 85 Södertälje, Sweden (SE)

Agent

1

Name:
ARONOVA S.A.
From:
31/05/2011
Address:
PO Box 327, L-4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

2

Name:
VAN MALDEREN JOELLE
From:
31/05/2011
Address:
ROUTE D'ARLON 261, 8002, STRASSEN, Luxembourg (LU)
To:
06/03/2024

Inventor

1

Name:
GUILE Simon Astra Charnwood
Address:
United Kingdom (GB)

2

Name:
HARDERN David Astra Charnwood
Address:
United Kingdom (GB)

3

Name:
WILLIS Paul Astra Charnwood
Address:
United Kingdom (GB)

4

Name:
INGALL Anthony Astra Charnwood
Address:
United Kingdom (GB)

5

Name:
SPRINGTHORPE Brian Astra Charnwood
Address:
United Kingdom (GB)

Publication

Bulletin

1

Bulletin Heading:
SPC3
Bulletin edition number:
2020/01
Publication date:
13/01/2020
Description:
Section E : Supplementary Protection certificates entered into force – IA publication

2

Bulletin Heading:
SPCX1
Bulletin edition number:
2022/05
Publication date:
01/04/2022
Description:
Section G : Applications for extensions for pediatric use – I1E publication

3

Bulletin Heading:
SPCX2
Bulletin edition number:
2024/05
Publication date:
03/04/2024
Description:
Section H : Granted extensions for pediatric use of supplementary protection certificates – I2E publication

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
28/11/2023
Last Annual Fee Paid Number:
25
Last Annual Fee Paid Amount:
450 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
17/03/2022 Marketing authorization 4
17/03/2022 Paediatric investigation plan 10
17/03/2022 Application Form 3
17/03/2022 Marketing authorization 4
17/03/2022 Summary of the product caracteristics 110
17/03/2022 Marketing authorization 3
17/03/2022 Outgoing Correspondence 1
06/03/2024 Outgoing Correspondence 1
27/03/2024 Certificate 1
17/03/2022 FNET_DC_FRONTPAGE 1
17/03/2022 Publication 1
27/03/2024 Publication 1
29/03/2024 Outgoing Correspondence 1